- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Shilpa Medicare Limited — Updates, 30-12-2025: General Updates
30-12-2025 | 01:24 pm
30-12-2025 | 01:24 pm
Shilpa Medicare and its subsidiaries received a court order halting manufacture/sale of a Ruxolitinib drug product over alleged patent infringement. The company states this product was for research only, expects no financial impact, and business operations are normal.
No comments yet. Be the first to comment!